Go to content
UR Home

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation

Dillmann, Johannes, Popp, Felix C., Fillenberg, Barbara, Zeman, Florian, Eggenhofer, Elke, Farkas, Stefan, Scherer, Marcus N., Koller, Michael, Geissler, Edward K., Deans, Robert, Ladenheim, Deborah, Loss, Martin, Schlitt, Hans-Jürgen and Dahlke, Marc H. (2012) Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation. Trials 13, p. 211.

[img]
Preview
License: Creative Commons Attribution 3.0
PDF - Published Version
Download (552kB)
Date of publication of this fulltext: 20 Mar 2013 12:50

at PubMed

at publisher (via DOI)


Abstract

BACKGROUND: Cellular therapy after organ transplantation is emerging as an intriguing strategy to achieve dose reduction of classical immunosuppressive pharmacotherapy. Here, we introduce a new scoring system to assess treatment-emergent adverse events (TEAEs) of adherent stem cell therapies in the clinical setting of allogeneic liver transplantation (for example, the MiSOT-I trial Eudract CT: ...

plus


Export bibliographical data



Item type:Article
Date:2012
Institutions:Medicine > Lehrstuhl für Chirurgie
Projects:Open Access Publizieren (DFG)
Identification Number:
ValueType
23151227PubMed ID
10.1186/1745-6215-13-211DOI
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Partially
Item ID:27951
Owner only: item control page

Downloads

Downloads per month over past year

  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons